This webinar from the British Society for Immunology's 'Connecting on coronavirus: the expert hub' series is hosted by Professor Danny Altmann on the topic ‘Antibody testing, neutralising monoclonals and other immune therapeutics: what we know and potential relevance to policy decisions'.
Danny Altmann is Professor of Immunology at Imperial College London, and has been Editor of several journals in academic immunology and vaccinology over the past 20 years, as well as a period in charge of 'Pathogens and Immunity strategy' at the Wellcome Trust.
In this session, he reviews new and exciting studies on COVID-19 immunology and emerging data from all around the world. He discusses what we're learning about SARS-CoV-2, including what immunologists understand by terms such as ‘correlates of protection’ or ‘neutralising monoclonal’, and how that information can be used to increase the public understanding and fed into decisions about how to tackle the pandemic.
The 'Connecting on coronavirus: the expert hub' webinar series is supported by the British Society for Immunology's official journals: Immunology, Clinical & Experimental Immunology and Immunotherapy Advances.